Emcure Pharmaceuticals Reports Robust Q3FY26 Performance with 20% Revenue Growth and 48% Profit After Tax Growth

Read More

Emcure Expands Weight Management Therapy Access with Launch of Poviztra®

Read More

Emcure Pharmaceuticals Reports Robust Q2FY26 Performance with 13% Revenue Growth and 25% Profit After Tax Growth

Read More

Novo Nordisk India partners with Emcure Pharma to commer – cialise Poviztra® in India as a second brand of Wegovy®

Read More

Press Release Emcure Q1FY26

Read More

Emcure Pharmaceuticals Ltd. and Sanofi India Limited Announce Exclusive Distribution Partnership to Broaden Reach of Sanofi’s Oral Anti-diabetic Drugs

Read More

Emcure Pharmaceuticals to Acquire Remaining Stake in its Subsidiary Zuventus Healthcare Ltd.

Read More

Emcure Joins the 2025 Ice Bucket Challenge Revival, but with a Twist around Mother’s Day

Read More

Emcure Pharmaceuticals Achieves Robust Q4FY25 Performance with 19% Revenue Growth and 63% Profit After Tax Growth

Read More

Emcure’s European subsidiary Tillomed acquires strategic pharma portfolio from Manx

Read More
Next